The global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek